share_log

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DICICCO WENDY F

SEC ·  Jan 7 16:09

Summary by Moomoo AI

EyePoint Pharmaceuticals, Inc. has reported a transaction involving Wendy F. DiCicco, scheduled for 01/03/2025. The filing indicates a future event, suggesting a planned transaction or vesting of securities.Specific details about the nature and volume of the transaction are not provided in the available information. The reporting person's address is listed as c/o EyePoint Pharmaceuticals, Inc., 480 Pleasant Street, Watertown, MA, 02472. No information is given regarding DiCicco's relationship to the issuer or her current shareholding status.Investors should note that this is a forward-looking report and the actual transaction may be subject to change. Further details may be disclosed closer to or on the transaction date.
EyePoint Pharmaceuticals, Inc. has reported a transaction involving Wendy F. DiCicco, scheduled for 01/03/2025. The filing indicates a future event, suggesting a planned transaction or vesting of securities.Specific details about the nature and volume of the transaction are not provided in the available information. The reporting person's address is listed as c/o EyePoint Pharmaceuticals, Inc., 480 Pleasant Street, Watertown, MA, 02472. No information is given regarding DiCicco's relationship to the issuer or her current shareholding status.Investors should note that this is a forward-looking report and the actual transaction may be subject to change. Further details may be disclosed closer to or on the transaction date.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated